These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 22437861)

  • 41. Access to essential drugs, human rights and global justice.
    Shalev C
    Monash Bioeth Rev; 2004 Jan; 23(1):S56-74. PubMed ID: 15835024
    [No Abstract]   [Full Text] [Related]  

  • 42. Improving global access to medicines for non-communicable diseases.
    Beran D; Perrin C; Billo N; Yudkin JS
    Lancet Glob Health; 2014 Oct; 2(10):e561-2. PubMed ID: 25304626
    [No Abstract]   [Full Text] [Related]  

  • 43. Right to health, essential medicines, and lawsuits for access to medicines--a scoping study.
    Vargas-Peláez CM; Rover MR; Leite SN; Rossi Buenaventura F; Farias MR
    Soc Sci Med; 2014 Nov; 121():48-55. PubMed ID: 25306409
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Twenty-five years of essential medicines.
    Quick JD; Hogerzeil HV; Velasquez G; Rago L
    Bull World Health Organ; 2002; 80(11):913-4. PubMed ID: 12481216
    [No Abstract]   [Full Text] [Related]  

  • 45. An economic justification for open access to essential medicine patents in developing countries.
    Flynn S; Hollis A; Palmedo M
    J Law Med Ethics; 2009; 37(2):184-208. PubMed ID: 19493066
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Supply chain transparency and the availability of essential medicines.
    Årdal C; Baraldi E; Beyer P; Lacotte Y; Larsson DJ; Ploy MC; Røttingen JA; Smith I
    Bull World Health Organ; 2021 Apr; 99(4):319-320. PubMed ID: 33953450
    [No Abstract]   [Full Text] [Related]  

  • 47. [Sources of medicines for chronic patients using the Brazilian Unified National Health System].
    Matta SR; Bertoldi AD; Emmerick ICM; Fontanella AT; Costa KS; Luiza VL;
    Cad Saude Publica; 2018 Mar; 34(3):e00073817. PubMed ID: 29590242
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Essential medicines for women and children].
    Lie SO; Apeland BG
    Tidsskr Nor Laegeforen; 2012 Oct; 132(19):2150. PubMed ID: 23076479
    [No Abstract]   [Full Text] [Related]  

  • 49. TRIPS, pharmaceutical patents, and access to essential medicines: a long way from Seattle to Doha.
    't Hoen E
    Chic J Int Law; 2002; 3(1):27-46. PubMed ID: 15709298
    [No Abstract]   [Full Text] [Related]  

  • 50. Falsified medicines in Africa: all talk, no action.
    Newton PN; Tabernero P; Dwivedi P; Culzoni MJ; Monge ME; Swamidoss I; Mildenhall D; Green MD; Jähnke R; de Oliveira MDS; Simao J; White NJ; Fernández FM
    Lancet Glob Health; 2014 Sep; 2(9):e509-e510. PubMed ID: 25304415
    [No Abstract]   [Full Text] [Related]  

  • 51. The essential drugs concept is needed now more than ever.
    Smith MK; Tickell S
    Trans R Soc Trop Med Hyg; 2003; 97(1):2-5. PubMed ID: 12886792
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Availability and affordability of essential medicines: exploring the health seeking behaviours and health service utilisation for children under-5 years living in squatter settlement of Karachi, Pakistan.
    Shafiq Y; Shaikh BT; Kumar R
    J Ayub Med Coll Abbottabad; 2011; 23(1):132-8. PubMed ID: 22830168
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Strategic procurement and international collaboration to improve access to medicines.
    Ferrario A; Humbert T; Kanavos P; Pedersen HB
    Bull World Health Organ; 2017 Oct; 95(10):720-722. PubMed ID: 29147045
    [No Abstract]   [Full Text] [Related]  

  • 54. Ensuring access to essential medicines: some economic considerations.
    Maskus KE
    Spec Law Dig Health Care Law; 2003 Jul; (291):9-25. PubMed ID: 15206162
    [No Abstract]   [Full Text] [Related]  

  • 55. Essential medicines for hepatitis C: at what price?
    Balakrishnan VS
    Lancet Infect Dis; 2017 Sep; 17(9):904-905. PubMed ID: 28845797
    [No Abstract]   [Full Text] [Related]  

  • 56. Fatima Suleman: making medicines more widely available.
    Bull World Health Organ; 2017 Dec; 95(12):800-801. PubMed ID: 29200520
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Legal and health variations in drug litigation injunctions granted in Minas Gerais.
    Coelho TL; Ferré F; Campos Neto OH; Acurcio Fde A; Cherchiglia ML; Andrade EI
    Rev Saude Publica; 2014 Oct; 48(5):808-16. PubMed ID: 25372172
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Evaluation of pharmaceutical assistance in public primary care in Brasilia, Brazil].
    Naves Jde O; Silver LD
    Rev Saude Publica; 2005 Apr; 39(2):223-30. PubMed ID: 15895142
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Medication access: all connected, all affected.
    Chisholm MA
    Am J Health Syst Pharm; 2003 Mar; 60(6):549. PubMed ID: 12659055
    [No Abstract]   [Full Text] [Related]  

  • 60. Commentary: will generic drug stores improve access to essential medicines for the poor in India?
    Kotwani A
    J Public Health Policy; 2010 Jul; 31(2):178-84. PubMed ID: 20535100
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.